Recent News


Alain Brunet starts an ambitious treatment program for victims of terrorist attacks in Paris

Dr. Alain Brunet, from the research centre, is involved in an ambitious project, developped with Paris hospitals, to treat victims of terrorist attacks in Paris who are suffering of Post-Traumatic Stress Disorder, or PTSD.  The treatment protocol,  developed by Dr Brunet and his team, aims to reduce the intensity of a painful memory using a drug called propanolol.  During the treatment, the painful memory is recalled while taking the drug, which acts to inhibit the reconsolidation of the highly emotional portion of the memory.

Pages


2018-05-07
New treatment approach could give quicker response times The discovery of a new mechanism involved in depression – and a way to target it with a drug as effective as classical antidepressants -- provides new understanding of this illness and could pave the way for treatments with fewer side effects. In a study published in Nature Medicine, a team of scientists at McGill University and France’s Institut national de la santé et de la recherche médicale (INSERM) examined...
2018-05-07
Study reveals what happens on the molecular level of 20,000 genes Have you ever considered that working night shifts may, in the long run, have an impact on your health? A team of researchers from the McGill University affiliated Douglas Mental Health University Institute (DMHUI) has discovered that genes regulating important biological processes are incapable of adapting to new sleeping and eating patterns and that most of them stay tuned to their daytime biological clock rhythms. In a study...
2018-03-26
Listen to a recent interview with Naguib Mechawar, Director of the Douglas Bell Canada Brain Bank, on Radio-Canada: http://ici.radio-canada.ca/premiere/emissions/les-eclaireurs/segments/entrevue/64098/banque-cerveaux-montreal-sante-mentale-etudes-depression-naguib-mechawar  

McGill Logo

CIUSSS ouest montreal logo